1.Saccharomyces boulardii versus Bacilus clausii for the treatment of acute diarrhea: a systematic review and meta – analysis.
Jose Ronilo G. JUANGCO ; Maribel Emma C. HIDALGO ; Nanette Y. Ramilo- CRUZ ; Raymond Oliver A. CRUZ ; Kathryn Floro- CRUZ ; Riezel Vanessa ABDON ; Ma. Leyhl Ann NIERVES ; Shalemar KASAN ; Jasmine SANGHILAN
Health Sciences Journal 2025;14(2):87-94
OBJECTIVES
This study aimed to evaluate the comparative efficacy of Saccharomyces boulardii and Bacillus clausii in the treatment of acute diarrhea
METHODSA systematic search of MEDLINE, EBSCO, Clinical Key, the Cochrane Library, Academia, and Google Scholar was conducted to identify clinical trials using Saccharomyces boulardii and Bacillus clausii as interventions. The primary outcome measure was the duration of diarrhea. Risk of bias was assessed using the CEBM Critical Appraisal tool and the Cochrane Collaboration tool. Data were analyzed using RevMan 5.4 software.
RESULTSFour studies involving 411 participants were included in the systematic review and meta-analysis. All studies demonstrated a weighted mean decrease in the duration of diarrhea, ranging from 4.70 to 25.20 hours, favoring Saccharomyces boulardii. The pooled analysis revealed a significant reduction of 24.98 hours in the duration of diarrhea, favoring Saccharomyces boulardii (p < 0.0001).
CONCLUSIONA systematic review and meta-analysis of four clinical trials showed that Saccharomyces boulardii is more effective than Bacilus clausii in reducing the duration of diarrhea among patients with acute diarrhea. These findings support the use of Saccharomyces boulardii as a preferred probiotic intervention for the treatment of acute diarrhea.
Plants
Result Analysis
Print
Save
E-mail